These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Obstacles to medication compliance for patients with glaucoma]. Kowal M; Choragiewicz T; Mietlicka K; WyszyĆska A; Zarnowski T Klin Oczna; 2008; 110(10-12):347-51. PubMed ID: 19195163 [TBL] [Abstract][Full Text] [Related]
24. Patterns and rate of adherence to glaucoma therapy using an electronic dosing aid. Ajit RR; Fenerty CH; Henson DB Eye (Lond); 2010 Aug; 24(8):1338-43. PubMed ID: 20339390 [TBL] [Abstract][Full Text] [Related]
25. Influence of parental health literacy and dosing responsibility on pediatric glaucoma medication adherence. Freedman RB; Jones SK; Lin A; Robin AL; Muir KW Arch Ophthalmol; 2012 Mar; 130(3):306-11. PubMed ID: 22411659 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of adherence to morning versus evening glaucoma medication dosing regimens. Kahook MY; Noecker RJ Clin Ophthalmol; 2007 Mar; 1(1):79-83. PubMed ID: 19668470 [TBL] [Abstract][Full Text] [Related]
27. [Improved eyedrop administration and compliance in glaucoma patients. A clinical study]. Busche S; Gramer E Klin Monbl Augenheilkd; 1997 Oct; 211(4):257-62. PubMed ID: 9445914 [TBL] [Abstract][Full Text] [Related]
28. Compliance with timolol treatment in glaucoma. Rotchford AP; Murphy KM Eye (Lond); 1998; 12 ( Pt 2)():234-6. PubMed ID: 9683946 [TBL] [Abstract][Full Text] [Related]
29. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. Stewart WC; Konstas AG; Pfeiffer N J Ocul Pharmacol Ther; 2004 Dec; 20(6):461-9. PubMed ID: 15684806 [TBL] [Abstract][Full Text] [Related]
30. Patients' problems with new medication for chronic conditions. Barber N; Parsons J; Clifford S; Darracott R; Horne R Qual Saf Health Care; 2004 Jun; 13(3):172-5. PubMed ID: 15175485 [TBL] [Abstract][Full Text] [Related]
31. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Friedman DS; Quigley HA; Gelb L; Tan J; Margolis J; Shah SN; Kim EE; Zimmerman T; Hahn SR Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5052-7. PubMed ID: 17962457 [TBL] [Abstract][Full Text] [Related]
32. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Olthoff CM; Hoevenaars JG; van den Borne BW; Webers CA; Schouten JS Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):235-43. PubMed ID: 18802720 [TBL] [Abstract][Full Text] [Related]
33. A clinician's guide to the assessment and management of nonadherence in glaucoma. Budenz DL Ophthalmology; 2009 Nov; 116(11 Suppl):S43-7. PubMed ID: 19837260 [TBL] [Abstract][Full Text] [Related]
34. Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Hahn SR Ophthalmology; 2009 Nov; 116(11 Suppl):S37-42. PubMed ID: 19837259 [TBL] [Abstract][Full Text] [Related]
35. Communication Predicts Medication Self-Efficacy in Glaucoma Patients. Carpenter DM; Blalock SJ; Sayner R; Muir KW; Robin AL; Hartnett ME; Giangiacomo AL; Tudor GE; Sleath BL Optom Vis Sci; 2016 Jul; 93(7):731-7. PubMed ID: 27003815 [TBL] [Abstract][Full Text] [Related]
36. Compliance with eye care in glaucoma patients with comorbid depression. Weiss GA; Goldich Y; Bartov E; Burgansky-Eliash Z Isr Med Assoc J; 2011 Dec; 13(12):730-4. PubMed ID: 22332441 [TBL] [Abstract][Full Text] [Related]
37. Preliminary survey of educational support for patients prescribed ocular hypotensive therapy. Gray TA; Fenerty C; Harper R; Lee A; Spencer AF; Campbell M; Henson DB; Waterman H Eye (Lond); 2010 Dec; 24(12):1777-86. PubMed ID: 20829888 [TBL] [Abstract][Full Text] [Related]